Joining the group as a technology developer and engineer
Integrated structure and metabolomics platform for microbial targets
Supported by the ARISE program, deadline November 30, 2021
We aim to establish a multidisciplinary metabolomics/structure service platform for determination of metabolic mechanisms of specific drugs or prodrugs by different microorganisms, in collaboration with Michael Zimmermann, Structural & Computational Biology Unit, EMBL Heidelberg. The platform will include establishment of a pipeline for high resolution structures of selected protein-drug complexes in microorganisms, and in-vitro analysis of the enzymatic processing of specific drugs by microorganisms.
In case of further interest please contact:
Matthias Wilmanns, EMBL Hamburg
Michael Zimmermann, EMBL Heidelberg
Externally funded fellowships are publicly advertised. Please inquire on general opportunities by contacting Matthias Wilmanns.
PhD applicants: Please apply through the EMBL International PhD Programme.
Masters students and trainees are expected for a minimum of 6 months.
For all applications please contact Matthias Wilmanns and attach your CV and a brief motivation letter of your research interests.